Open AccessIvabradine Monotherapy for the Treatment of Congenital Junctional Ectopic Tachycardia in a Premature Neonate
Author(s) -
Suzan S. Asfour,
Khalid Alomran,
Nabeel A Alodhaidan,
Raneem S. Asfour,
Thanaa M. Khalil,
Mountasser M. Al-Mouqdad
Publication year - 2021
Publication title -
the journal of pediatric pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 15
eISSN - 2331-348X
pISSN - 1551-6776
DOI - 10.5863/1551-6776-26.4.414
Subject(s) - ivabradine , medicine , cardiology , tachycardia , supraventricular tachycardia , angina , ventricular tachycardia , anesthesia , heart rate , myocardial infarction , blood pressure
Congenital junctional ectopic tachycardia is a rare and special type of supraventricular arrhythmia. Junctional ectopic tachycardia is characterized by persistently elevated heart rates that may cause an impairment in cardiac function. Junctional ectopic tachycardia is considered one of the most difficult-to-treat conditions even with a combination of antiarrhythmic medications. Ivabradine is a novel antiarrhythmic medication used to decrease the heart rate in adults with angina pectoris. We report a first case of a premature neonate with a normal heart structure who developed junctional ectopic tachycardia and was subsequently treated successfully with ivabradine.